IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
NOVARTIS
Full Name: Novartis Ar gen tina S.A.
Street Ad dress: Ramallo 1851, 1429 Bue nos Ai -
res
Tel: +54 11 4703-7000
Fax: +54 11 4703-7188
Home Page: www.ar.novartis.com
De scrip tion: Es tab lished 1997. Di vi sions in -
clude: Novartis OTC.
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 70-75 mil lion
Prod ucts (% of Sales by Lead ing 5): 50-55%
Ther a peu tic Classes (% of Sales by Lead ing
5): 60-65%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
TEGRETOL (antiepileptic)
DIOVAN (an gio ten sin-II an tag o nist plain)
RELIVERAN (gastroprokinetic)
TRILEPTAL (antiepileptic)
DIOVAN-D (an gio ten sin-II an tag o nist com bi na -
tion)
Ther a peu tic Range:
antiepileptics 23%
renin-an gio ten sin sys tem agents 20%
func tional gas tro-in tes ti nal dis or der drugs 10%
antithrombotic agents 6%
anti rheu ma tics sys temic 5%
Lead ing Dose Forms:
tab lets 48%
coated tab lets 30%
liq uids 12%
cap sules 4%
am poules 3%
SANDOZ
Full Name: Sandoz S.A.
Street Ad dress: Av Cramer 4130, C1429AJZ
Bue nos Ai res
Tel: +54 11 4704-2401
Fax: +54 11 4701-8754
De scrip tion: De vel oper, man u fac turer, for mu la -
tor, packager/as sem bler, im porter, ex porter, dis -
trib u tor, pro moter, sales/detailer. Man u fac tures,
ex ports, dis trib utes for other com pa nies. Prod uct
ranges in clude: phar ma ceu ti cal prod ucts
(branded, pre scrip tion, non-pre scrip tion), hos pi -
tal pharmaceuticals. Es tab lished 1946. 300
pharmaceutical employees in 2006.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 51-100 (2006)
Con tacts (Pharm): Chair man: Ignacio
Ketelhohn; Com mer cial Op er a tions: Roberto
Carlucci; Man u fac ture: Dan iel San Juan; Mar ket
Re search: Ce cilia Bollero; Re search & De vel op -
ment: Silvia Dominguez; Gen eral Con tact: Cecilia
Bollero
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 28-30 mil lion
Prod ucts (% of Sales by Lead ing 5): 40-45%
Ther a peu tic Classes (% of Sales by Lead ing
5): 50-55%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
LABISTATIN (cho les terol/triglyceride reg u lat ing
prep a ra tion)
TAMSUNA (BPH (be nign pros tatic hy per tro phy)
prod uct)
ALLOPURINOL-INCA (antigout prep a ra tion)
VARTALON COMPLEMEN (musculoskeletal prod -
uct other)
SOLUTRAT (bile ther apy/cholagogue)
Ther a peu tic Range:
lipid-reg u lat ing/antiatheroma prep a ra tions
16%
musculoskeletal drugs other 13%
urologicals 10%
antigout prep a ra tions 8%
antibacterials sys temic 7%
Lead ing Dose Forms:
tab lets 38%
coated tab lets 25%
cap sules 20%
pow ders/gran ules 11%
liq uids 3%
AUSTRALIA
CIBA VI SION
Full Name: CIBA Vi sion Aus tra lia Pty Ltd
Postal Ad dress: Pri vate Bag 100, Baulk ham Hills
Busi ness Cen tre, Baulk ham Hills, NSW 2153
Street Ad dress: 1/42 Car ring ton Rd, Cas tle Hill,
NSW 2154
Tel: +61 2 9680 6655
Fax: +61 2 9899 9430
Home Page: www.cibavision.com.au
De scrip tion: Man u fac turer, packager/as sem -
bler, im porter, dis trib u tor, pro moter,
sales/detailer. Prod uct ranges in clude: phar ma -
ceu ti cal prod ucts (branded, pre scrip tion,
non-pre scrip tion), oph thal mic prod ucts. Es tab -
© 2009 IMS Health In cor po rated or its af fil i ates Page 148